Medicina
Facultad
Centro Nacional de Biotecnología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Biotecnología (141)
2024
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2
Advanced Science, Vol. 10, Núm. 34
-
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver
Molecular Genetics and Metabolism Reports, Vol. 35
-
IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis
Cell Reports, Vol. 42, Núm. 12
-
Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8+ T cells
Nature Communications, Vol. 14, Núm. 1
-
MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells
Oncogene, Vol. 42, Núm. 45, pp. 3358-3370
-
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
Frontiers in Immunology, Vol. 14
-
N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile
Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483
-
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
Frontiers in Immunology, Vol. 14
-
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
Frontiers in Immunology, Vol. 14
-
The first year of young group of the Spanish Immunology Society: Progress, challenges, and next steps
European Journal of Immunology
2022
-
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
Frontiers in Immunology, Vol. 12
-
Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21
-
Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice
npj Vaccines, Vol. 7, Núm. 1
-
Infusion of haploidentical NKG2D-CAR-TCD45RA- cells in two pediatric patients with advanced relapsed and refractory acute leukemia was safe but achieved no clinical benefits
Leukemia and Lymphoma
-
Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection
Frontiers in Immunology, Vol. 13
-
Molecular Classification of Colorectal Cancer by microRNA Profiling: Correlation with the Consensus Molecular Subtypes (CMS) and Validation of miR-30b Targets
Cancers, Vol. 14, Núm. 21
-
New insights into the role of endosomal proteins for African swine fever virus infection
PLoS Pathogens, Vol. 18, Núm. 1